“Welcome to Big Pharma, where you can make a fortune and still maintain a healthy conscience. Or can you?”

Our understanding of the differences in male and female biology is constantly growing – but can we translate that knowledge into better healthcare for all?

We speak to Derek Gatherer from the Division of Biomedical and Life Sciences at Lancaster University, UK, to get an overview of the Ebola outbreak.

Manufacturing stem cells for use in research is one thing; doing it on a commercial scale is an entirely different ballgame.

Antibiotics were once hailed as wonder drugs in the war against infection, but now it looks like bacteria might have the upper hand. How can we turn the tide?

An FDA Warning Letter can be a real wake up call. How can you address the root of the problem?

Sitting Down With… Wim Leereveld, founder and CEO of the Access to Medicine Foundation

Maximizing operational excellence – what have we learned and where do we go next?

Today’s pharmaceutical manufacturing operations capture huge amounts of data. Unfortunately, in many cases the data pass by without actual context.

Guillaume Plane takes us on a tour of the facility of the near future.